Publicacións nas que colabora con Eva Poveda López (30)

2023

  1. High Levels of IL-1β, TNF-α and MIP-1α One Month after the Onset of the Acute SARS-CoV-2 Infection, Predictors of Post COVID-19 in Hospitalized Patients

    Microorganisms, Vol. 11, Núm. 10

  2. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  3. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  4. Meningococcal carriage in men who have sex with men presenting at a sexual health unit in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 3, pp. 287-296

2022

  1. Author Correction: Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study (Scientific Reports, (2022), 12, 1, (3369), 10.1038/s41598-022-07414-x)

    Scientific Reports

  2. Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients

    PLoS ONE, Vol. 17, Núm. 7 July

  3. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  4. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

    Scientific reports, Vol. 12, Núm. 1, pp. 3369

  5. Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control

    The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049

  6. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836

  7. Real-life cohort experience after implementing HIV pre-exposure prophylaxis for one year in northwest Spain

    Frontiers in Public Health, Vol. 10

  8. Two-Drug Regimens for HIV—Current Evidence, Research Gaps and Future Challenges

    Microorganisms, Vol. 10, Núm. 2

  9. Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection

    Microorganisms, Vol. 10, Núm. 5

2021

  1. Aptamer Sandwich Assay for the Detection of SARS-CoV-2 Spike Protein Antigen

    ACS Omega, Vol. 6, Núm. 51, pp. 35657-35666

  2. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  3. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

    Cellular and Molecular Immunology, Vol. 18, Núm. 9, pp. 2128-2139

2020

  1. Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study

    AIDS Research and Therapy, Vol. 17, Núm. 1

  2. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

    The Lancet HIV, Vol. 7, Núm. 8, pp. e565-e573

2019

  1. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra Leone: A prospective study

    BMC Public Health, Vol. 19, Núm. 1

  2. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2